Tokyo, Japan

Takashi Nishizato

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Takashi Nishizato: A Leader in Pharmaceutical Patents

Introduction: Takashi Nishizato is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the pharmaceutical industry. With a portfolio that includes five patents, Nishizato focuses on developing innovative pharmaceutical compositions with modified release properties.

Latest Patents: Nishizato's latest patents revolve around advanced formulations for sustained release. One notable patent describes a pharmaceutical composition comprising (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or its pharmaceutically acceptable salts, designed to achieve a maximum blood drug concentration of 400 ng/ml or less when administered in a fasted state. Another patent outlines a unique pharmaceutical composition that includes this same compound, along with additives that promote water penetration and a hydrogel-forming polymer. These inventions aim to enhance the efficacy and safety of drug delivery systems.

Career Highlights: Takashi Nishizato currently works at Astellas Pharma GmbH, a leading global pharmaceutical company. His role involves researching and developing innovative drug formulations that address ongoing medical needs. The impact of his work is reflected in the patents he holds, showcasing a commitment to advancing pharmaceutical science.

Collaborations: Throughout his career, Nishizato has collaborated with esteemed professionals in the field, including Yutaka Takahashi and Daisuke Murayama. These collaborations highlight the importance of teamwork and knowledge sharing in the pursuit of innovation within the pharmaceutical sector.

Conclusion: Takashi Nishizato's inventive spirit and dedication to pharmaceutical research have positioned him as a key figure in the industry. With five patents to his name, his contributions, particularly in the area of modified release pharmaceutical compositions, demonstrate the potential for innovation to enhance patient outcomes. His continued work at Astellas Pharma GmbH promises further advancements that could transform healthcare practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…